Skip to content
value.today

Humanigen Inc.

HGENUnlisted company
$13 Mlast known market cap, Dec 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

About Humanigen Inc.

Humanigen, Inc is a Clinical Stage Biopharmaceutical company developing immunology and immuno oncology portfolio of monoclonal antibodies. It is having 68.3 million USD as on 2020. The headquarters is in USA.

More about Humanigen Inc.

Acquisitions and changes
No longer listed: it is not in the SEC's, Nasdaq Trader's and FINRA's lists of US-traded securities (checked 14 November 2026).

Market cap history

$0 M$50 M$101 M$151 M$202 M

World rank over time

unchanged since 2022
2022-01-07: #19177#19,17720222022-12-25: #19177#19,1772022

Rank in USA: #3,901 (Jan 2022) · #5,472 (Dec 2022)

Lobbying by Humanigen Inc.#

$140 K spent on lobbying the US Congress and federal agencies in 2021, most often on budget/appropriations, health issues and manufacturing.

Lobbying, 2021
$140 K
#954 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
2
in 2021
2026 so far
—
  • Budget/Appropriations3 reports
  • Health Issues3 reports
  • Manufacturing3 reports
  • Medical/Disease Research/Clinical Labs3 reports

Lobbying firms hired in 2021

Van Scoyoc Associates $130 K · HOLLIS PUBLIC AFFAIRS $10 K

Humanigen Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2021$140 K—4
2020$60 K—2

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Humanigen, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Humanigen Inc.🇺🇸$13 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Dec 25, 2022 (last known)
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Humanigen Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Humanigen Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Humanigen Inc.? Suggest a correction